• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

Gilde Investment (Group)

Gilde Healthcare (Utrecht, The Netherlands and Cambridge, MA, USA) is a transatlantic investment firm specialized in healthcare. It has over €450 million ($600 million) under management in four funds. Apart from three funds dedicated to technological innovations, Gilde Healthcare manages a separate fund aimed at mid-market healthcare service companies. *

 

	Start	1982-01-01 established
	Industry	investment banking
	Person	de Graaf, Edwin (Gilde Investment 201409 Managing Director at Gilde Healthcare)
	Region	Utrecht
	Country	Netherlands
	Street	91 Newtonlaan
	City	3584 BP Utrecht
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	450,000,000 (capital under management 2013-11-26)
		* Document for �About Section�:
		Record changed: 2021-05-01

Advertisement

More documents for Gilde Investment (Group)

• [1] Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden....
• [2] Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht....
• [3] Gilde Healthcare Partners. (12/14/21). "Press Release: Philips Acquires Gilde Portfolio Company Vesper Medical to Further Expand Its Image-guided Therapy Devices Portfolio". Amsterdam & Utrecht....
• [4] Gilde Healthcare Partners. (6/2/21). "Press Release: Gilde Healthcare Appoints Joep Muijrers to Lead Investments in Public Markets". Utrecht....
• [5] Gilde Healthcare Partners. (5/6/21). "Press Release: Gilde Healthcare Acquires Majority Stake in Danish Drug Development Consultancy KLIFO to Support International Growth Ambitions". Utrecht & Copenhagen....
• [6] Volta Medical. (1/5/21). "Press Release: Volta Medical Raises 28 Million USD to Revolutionize Persistent AFib Ablation". Marseille....
• [7] CVRx, Inc.. (7/7/20). "Press Release: CVRx Raises $50 Million in New Equity Financing. Offering Will Support US Commercialization of Barostem Neo". Minneapolis, MN....
• [8] Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 Million ($450 Million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA....
• [9] Gilde Healthcare Partners. (3/7/19). "Press Release: Gilde Healthcare Raises €200 Million for New Private Equity Fund. Targeting Lower Mid-market Healthcare Investments in the Benelux and DACH Regions". Utrecht & Frankfurt a. M.....
• [10] Calypso Biotech S.A.. (2/20/19). "Press Release: Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases". Amsterdam....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.